Skip to content
★ Sign in to follow
DW

Didier Wimmers

Executive
Aehr Test Systems
Insider activity · 24 months0 buys2 salesCumulative net flow
Total declarations
12
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€327k

Latest filing published 02 Oct 2026 for Aehr Test Systems, €7,716.

Filing timeline

BuySale
Didier Wimmers

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

Didier Wimmers: trading record in brief

Didier Wimmers appears in our data through filings on Aehr Test Systems shares, published by SEC (Form 4). The record holds 12 filings, for trades running from 3 September 2025 to 1 October 2026.

Sales make up the whole of the open-market record (2 sales, €327k). Besides market trades, the filings include 7 share grants. So far in 2026, the count stands at no purchases and 2 sales.

Most recently, on 2 October 2026, the filings show a transaction worth €7,716 in Aehr Test Systems. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Didier Wimmers

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ●
    Executive VP of R&DExecutivesAehr Test Systems
    8,748 USD0SEC
    1,311 shares@ US$6.6725Common StockSEC:0001040470-26-000277:0
  • ◆
    Executive VP of R&DExecutivesAehr Test Systems
    5,486 USD0SEC
    54 shares@ US$101.60Common StockSEC:0001040470-26-000277:1
  • ◆
    Executive VP of R&DExecutivesAehr Test Systems
    24,178 USD17SEC
    317 shares@ US$76.270.0007% mcap4.9% of flowCommon StockSEC:0001040470-26-000265:0
  • ◆
    Executive VP of R&DExecutivesAehr Test Systems
    0SEC
    2,369 sharesCommon StockSEC:0001040470-26-000197:0
  • ◆
    Executive VP of R&DExecutivesAehr Test Systems
    38,044 USD12SEC
    332 shares@ US$114.590.0011% mcap7.6% of flowCommon StockSEC:0001040470-26-000168:0
  • ▼
    Executive VP of R&DExecutivesAehr Test Systems
    248,886 USD34SEC
    3,500 shares@ US$71.11020.0061% mcap49.4% of flowCommon StockSEC:0001040470-26-000110:0
  • ▼
    Executive VP of R&DExecutivesAehr Test Systems
    136,845 USD32SEC
    1,900 shares@ US$72.02390.0034% mcap27.1% of flowCommon StockSEC:0001040470-26-000110:1
  • ●
    Executive VP of R&DExecutivesAehr Test Systems
    12,498 USD11SEC
    1,873 shares@ US$6.67252.5% of flowCommon StockSEC:0001040470-26-000077:0
  • ◆
    Executive VP of R&DExecutivesAehr Test Systems
    15,157 USD11SEC
    364 shares@ US$41.643.0% of flowCommon StockSEC:0001040470-26-000058:0
  • ◆
    Executive VP of R&DExecutivesAehr Test Systems
    9,186 USD11SEC
    371 shares@ US$24.761.8% of flowCommon StockSEC:0001040470-25-000084:0
  • ●
    Executive VP of R&DExecutivesAehr Test Systems
    10,863 USD11SEC
    1,628 shares@ US$6.67252.2% of flowCommon StockSEC:0001040470-25-000019:0
  • ◆
    Executive VP of R&DExecutivesAehr Test Systems
    7,552 USD11SEC
    308 shares@ US$24.521.5% of flowCommon StockSEC:0001593968-25-000992:0

12 of 12 declarations